Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Alireza Khorramimoghaddam"'
Autor:
Javad Biabani Ardakani, Seyed Mohammad Abedi, Alireza Mardanshahi, Leyla Shojaee, Ehsan Zaboli, Alireza Khorramimoghaddam, Anahita Nosrati, Hamideh Sabahno, Elahm Sadat Banimostafavi, Seyed Jalal Hosseinimehr
Publikováno v:
Clinical Breast Cancer. 23:219-230
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b5a6a9af3da9541ab4693e1cd64a06a
https://doi.org/10.1016/j.clbc.2022.12.002
https://doi.org/10.1016/j.clbc.2022.12.002
Autor:
Sajjad Molavipordanjani, Tahoora Mousavi, Alireza Khorramimoghaddam, Fereshteh Talebpour Amiri, Seyed Mohammad Abedi, Seyed Jalal Hosseinimehr
Publikováno v:
Annals of Nuclear Medicine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5488f59efda2775f2ad48949b18c46b
https://doi.org/10.1007/s12149-023-01839-8
https://doi.org/10.1007/s12149-023-01839-8
Autor:
Javad, Biabani Ardakani, Seyed Mohammad, Abedi, Alireza, Mardanshahi, Leyla, Shojaee, Ehsan, Zaboli, Alireza, Khorramimoghaddam, Anahita, Nosrati, Hamideh, Sabahno, Elahm Sadat, Banimostafavi, Seyed Jalal, Hosseinimehr
Publikováno v:
Clinical breast cancer.
The accurate determination of human epidermal growth factor receptor 2 (HER2) status can predict response to treatment with HER2-targeted therapy for HER2-positive breast cancer. [In total, 24 women with suspected primary breast cancer received an in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1d9e5af399c243538cea47d696a2d66f
https://pubmed.ncbi.nlm.nih.gov/36581518
https://pubmed.ncbi.nlm.nih.gov/36581518
Autor:
Javad, Biabani Ardakani, Fereshteh, Talebpour Amiri, Alireza, Khorramimoghaddam, Ali, Abbasi, Sajjad, Molavipordanjani, Seyed Jalal, Hosseinimehr
Publikováno v:
Regulatory toxicology and pharmacology : RTP. 112
Accurate assessment of the HER2 expression is an essential issue for predicting response to anti-HER2 therapy in breast cancer patients. The aim of this study was to evaluate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9ac390e60536cbc7ccf28bc6e91dde5e
https://pubmed.ncbi.nlm.nih.gov/32006673
https://pubmed.ncbi.nlm.nih.gov/32006673
Autor:
Ali Abbasi, Seyed Jalal Hosseinimehr, Javad Biabani Ardakani, Alireza Khorramimoghaddam, Fereshteh Talebpour Amiri, Sajjad Molavipordanjani
Publikováno v:
Regulatory Toxicology and Pharmacology. 112:104591
Accurate assessment of the HER2 expression is an essential issue for predicting response to anti-HER2 therapy in breast cancer patients. The aim of this study was to evaluate 99mTc-HYNIC-(Ser)3-LTVPWY (99mTc-HYNIC-LY) peptide as a novel HER2-targeted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f33138e925bd1b97004eb0e8ae52065
https://doi.org/10.1016/j.yrtph.2020.104591
https://doi.org/10.1016/j.yrtph.2020.104591